|
|
|
|
Evaluating Hepatitis Delta Virus Disease Prevalence and
Patient Characteristics Among Adults in the United States:
An Analysis of All-Payer Claims Database
|
|
|
EASL 2022 June 22-26 London
Robert G. Gish,1,2 Ira M. Jacobson,3 Joseph K. Lim,4 Ankita Kaushik,5 Yan Liu,5 Anissa Cyhaniuk,6 Robert Wong7
1University of Nevada, Reno School of Medicine, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV, USA; 2UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, Hepatitis B. Foundation, La Jolla, CA, US; 3NYU Grossman School of Medicine, New York, NY, US; 4Yale School of Medicine, New Haven, CT, US; 5Gilead Sciences, Inc., Foster City, CA, US; 6STATinMED, Plano, TX, US; 7Stanford University School of Medicine, Stanford and VA Palo Alto Healthcare System, Palo Alto, CA, US
|
|
|
|
|
|
|